Physical Activity and Survival After Prostate Cancer

Slides:



Advertisements
Similar presentations
Volume 59, Issue 2, Pages (February 2011)
Advertisements

The PSA Era is not Over for Prostate Cancer
Volume 59, Issue 2, Pages (February 2011)
Volume 51, Issue 2, Pages (February 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 4, Pages (April 2008)
Volume 70, Issue 6, Pages (December 2016)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Volume 72, Issue 5, Pages (November 2017)
Volume 59, Issue 2, Pages (February 2011)
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
Volume 68, Issue 5, Pages (November 2015)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 150, Issue 4, Pages e1 (April 2016)
Volume 68, Issue 5, Pages (November 2015)
Volume 54, Issue 4, Pages (October 2008)
Volume 68, Issue 5, Pages (November 2015)
Volume 63, Issue 6, Pages (June 2013)
Prostate Cancer Detection: A View of the Future
Volume 67, Issue 3, Pages (March 2015)
Volume 70, Issue 4, Pages (October 2016)
Volume 69, Issue 3, Pages (March 2016)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
Volume 71, Issue 6, Pages (June 2017)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 53, Issue 2, Pages (February 2008)
Volume 64, Issue 4, Pages (October 2013)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Leonard S. Marks, Jiaoti Huang  European Urology 
Volume 53, Issue 4, Pages (April 2008)
Volume 66, Issue 2, Pages (August 2014)
Volume 63, Issue 3, Pages (March 2013)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 74, Issue 2, Pages (August 2018)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Re: Christine McKillop
Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Volume 52, Issue 6, Pages (December 2007)
Volume 71, Issue 5, Pages (May 2017)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 59, Issue 4, Pages (April 2011)
European Urology is “Your” Journal
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 51, Issue 2, Pages (February 2007)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Does PSA Testing Influence the Natural History of Prostate Cancer?
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Physical Activity and Survival After Prostate Cancer Christine M. Friedenreich, Qinggang Wang, Heather K. Neilson, Karen A. Kopciuk, S. Elizabeth McGregor, Kerry S. Courneya  European Urology  Volume 70, Issue 4, Pages 576-585 (October 2016) DOI: 10.1016/j.eururo.2015.12.032 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Study timeline for the Prostate Cohort Study, Alberta, Canada, 1997–2014. The number of deaths is indicated for 830 men with prostate cancer who completed the first physical activity follow-up interview. European Urology 2016 70, 576-585DOI: (10.1016/j.eururo.2015.12.032) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 2 Kaplan-Meier curves for postdiagnosis total physical activity in relation to (A) all-cause mortality and (B) prostate cancer–specific death in the Prostate Cohort Study, Alberta, Canada, 1997–2014. MET=metabolic equivalent; Q=quartile. European Urology 2016 70, 576-585DOI: (10.1016/j.eururo.2015.12.032) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 3 Kaplan-Meier survival curves for change in recreational physical activity from prediagnosis to postdiagnosis of prostate cancer (PCa) in relation to (A) all-cause mortality and (B) PCa-specific mortality in the Prostate Cohort Study, Alberta, Canada, 1997–2014. Subgroups were defined based on tertiles of average physical activity before and after diagnosis; high represents the highest tertile, and low-moderate represents the lowest and middle tertiles (defined in Supplementary Table 5). Postdiagnosis activity represents average activity across follow-up questionnaires 1, 2, and 3 (for participants who did not complete three assessments, the average was derived from one or two assessments). European Urology 2016 70, 576-585DOI: (10.1016/j.eururo.2015.12.032) Copyright © 2015 European Association of Urology Terms and Conditions